Recruiting A Phase I Study of LXP1788 Injection with Advanced Solid Tumors. NCT06883539 Conditions Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +31 more Locations China Medical University Hospital — Taichung, Taiwan National Cheng Kung University Hospital — Tainan, Taiwan View Trial Details
Not Yet Recruiting A Multicenter, Open-label, Randomized Controlled Trial Evaluating the Efficacy and Safety of Romiplostim N01 in the Treatment of Thrombocytopenia Associated With Concurrent/Sequential Chemoradiotherapy and Chemotherapy Combined With/Without Immunotherapy in Solid Tumors NCT07185893 Conditions Blood Platelet Disorders, CTIT-Chemotherapy Induced Thrombocytopenia, Cytopenia, +5 more Locations The Fourth Hospital of Hebei Medical University — Shijiazhuang, Hebei, China View Trial Details
Completed An Open-Label Study of E7974 Administered on Days 1, 8, and 15 of a 28-Day Cycle and Days 1 and 8 of a 21-Day Cycle in Patients With Solid Malignancies NCT00121732 Conditions Neoplasms, Solid Tumor Malignancies, Cancer Locations Indiana University — Indianapolis, Indiana, United States CTRC — San Antonio, Texas, United States View Trial Details
